Prognostic impact of HER2 overexpression/amplification in women with pT1a N0 M0 breast cancer with known screening status: First results from a multicenter population based cancer registry study / Musolino, A; Michiara M; Boggiani D; Sikokis A; Rimanti A; Pellegrino B; Martella E; Bozzani F; Sgargi P; Panebianco M; Bisagni G; Falcini F; Pinto, C. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - (2015).

Prognostic impact of HER2 overexpression/amplification in women with pT1a N0 M0 breast cancer with known screening status: First results from a multicenter population based cancer registry study

MUSOLINO A;
2015-01-01

2015
Prognostic impact of HER2 overexpression/amplification in women with pT1a N0 M0 breast cancer with known screening status: First results from a multicenter population based cancer registry study / Musolino, A; Michiara M; Boggiani D; Sikokis A; Rimanti A; Pellegrino B; Martella E; Bozzani F; Sgargi P; Panebianco M; Bisagni G; Falcini F; Pinto, C. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - (2015).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2874841
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact